Health Mechanisms of resistance to sotorasib in lung cancer identified by Alexandra Hartman Editor-in-Chief March 17, 2023 written by Alexandra Hartman Editor-in-Chief March 17, 2023 30 Oncology – First approved inhibitor once morest the KRAS oncogene. First approved inhibitor once morest the KRAS oncogene. Tumor cells rapidly adapt to the drug by increasing the number of copies of the mutated KRAS targeted by therapy. Sotorasib-resistant lung cancer cells carrying multiple copies of the mutated KRAS gene (in red). Photo: CICANCER. Share this: Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Related 0 comments 0 FacebookTwitterPinterestEmail Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity. previous post Biden asks Congress to strengthen the powers of banking regulators next post Profini.sk » The Department of Investments centrally procures cloud services for more than 30 million euros for five years You may also like 2025 Health: Measles, AI Viruses & Top Medical... December 28, 2025 Back Pain: Causes, Relief & When to See... December 28, 2025 Brittle Bone Disease: OI Symptoms, Causes & Treatment December 28, 2025 Dementia Breakthrough: New Treatment Reverses Memory Loss? December 28, 2025 New Materials Boost Computer Memory & Chip Speed December 28, 2025 Ferritin & Hair Loss: Telogen Effluvium in Women December 28, 2025 Belonging & Home: Identity, Memory & the Meaning... December 28, 2025 Rare Lung Cancer & Fibrosis: Absent Pulmonary Artery... December 28, 2025 Webb Telescope Reveals Mysterious Molecular Cloud 🌌 December 28, 2025 Brain Health & Respiratory Protection: A New Defense December 28, 2025 Leave a Comment Cancel Reply Δ This site uses Akismet to reduce spam. Learn how your comment data is processed.
